Literature DB >> 11836118

Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.

G Bruno1, L Costantino, C Curinga, R Maccari, F Monforte, F Nicoló, R Ottanà, M G Vigorita.   

Abstract

Several (Z)-5-arylidene-2,4-thiazolidinediones were synthesized and tested as aldose reductase inhibitors (ARIs). The most active of the N-unsubstituted derivatives (2) exerted the same inhibitory activity of Sorbinil. The introduction of an acetic side chain on N-3 of the thiazolidinedione moiety led to a marked increase in lending inhibitory activity, conducting to the discovery of a very potent ARI (4c), whose activity level (IC50=0.13 microM) was in the same range of Tolrestat. Moreover, the corresponding methyl esters (3), devoid of any acidic functionality, showed appreciable inhibitory activity similar to that of the N-unsubstituted compounds. It was also found that the substitution pattern on the 5-benzylidene moiety markedly influenced the activity of N-unsubstituted 2,4-thiazolidinediones 2, compounds with substituents at the meta position being generally more effective than the para-substituted ones; however, this SAR was not evidenced in acetates 3 and acids 4.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836118     DOI: 10.1016/s0968-0896(01)00366-2

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  31 in total

1.  One-pot synthesis of 5-arylidene-2-imino-4-thiazolidinones under microwave irradiation.

Authors:  Souad Kasmi-Mir; Ayada Djafri; Ludovic Paquin; Jack Hamelin; Mustapha Rahmouni
Journal:  Molecules       Date:  2006-08-10       Impact factor: 4.411

2.  Testing the ability of rhodanine and 2, 4-thiazolidinedione to interact with the human pancreatic alpha-amylase: electron-density descriptors complement molecular docking, QM, and QM/MM dynamics calculations.

Authors:  Rajendran Niranjana Devi; Maria G Khrenova; Samuel Israel; Chellam Anzline; Andrey A Astakhov; Vladimir G Tsirelson
Journal:  J Mol Model       Date:  2017-08-05       Impact factor: 1.810

3.  An efficient microwave assisted synthesis of novel class of Rhodanine derivatives as potential HIV-1 and JSP-1 inhibitors.

Authors:  Sukanta Kamila; Haribabu Ankati; Edward R Biehl
Journal:  Tetrahedron Lett       Date:  2011-08-24       Impact factor: 2.415

4.  Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.

Authors:  Zuping Xia; Christian Knaak; Jian Ma; Zanna M Beharry; Campbell McInnes; Wenxue Wang; Andrew S Kraft; Charles D Smith
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

5.  Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.

Authors:  S Vijaya Laxmi; P Anil; G Rajitha; Asha Jyothi Rao; Peter A Crooks; B Rajitha
Journal:  J Chem Biol       Date:  2016-07-15

6.  Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.

Authors:  N N Patel; C M Crincoli; E L Kennedy; D M Frederick; R Tchao; P J Harvison
Journal:  Xenobiotica       Date:  2008-04       Impact factor: 1.908

7.  3-Phenyl-2-thioxo-1,3-thia-zolidin-4-one.

Authors:  Feng-Xia Zhu; Jian-Feng Zhou; Gui-Xia Gong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-24

8.  Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.

Authors:  Christine M Crincoli; Niti N Patel; Ruy Tchao; Peter J Harvison
Journal:  Toxicology       Date:  2008-06-25       Impact factor: 4.221

9.  CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors.

Authors:  Hong-Yan Liu; Shu-Shen Liu; Li-Tang Qin; Ling-Yun Mo
Journal:  J Mol Model       Date:  2009-01-09       Impact factor: 1.810

10.  Induced fit docking, pharmacophore modeling, and molecular dynamic simulations on thiazolidinedione derivatives to explore key interactions with Tyr48 in polyol pathway.

Authors:  Manga Vijjulatha; Yamini Lingala; RaviRaja Tejaswi Merugu
Journal:  J Mol Model       Date:  2014-06-29       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.